HIV care providers are running out of medicine thanks to Trump’s foreign aid cuts
A survey by the International Planned Parenthood Foundation indicates that global HIV care providers are facing critical shortages of medicine and testing resources. These shortages are attributed to a significant reduction in U.S. foreign aid funding for HIV programs.
Why it matters
The reduction in international health funding threatens to reverse decades of progress in managing the global HIV epidemic.
Boxes of medicines sit on a desk. A medical provider sits behind the desk. Healthcare providers around the world are running short on crucial HIV medicines since President Donald Trump began cutting foreign aid for HIV care last year.
The International Planned Parenthood Foundation , which supports sexual and reproductive healthcare globally, recently surveyed its member organizations and found that more than half of respondents had run out of certain HIV medicines or resources in the last year. The survey included 40 of the foundation's 102 member associations globally.
"Without reliable access to these basic commodities, the established service delivery capacity of [member organizations] will not translate into uninterrupted care for clients," a survey report released this month reads.
HIV test shortages were the most common form of shortage among respondents, and barriers to accessing condoms and pre-exposure prophylaxis, or PrEP, were also widely observed.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in